Likozam

Clobazam, the active ingredient in Likozam, is a benzodiazepine presented as an oral dosage form for oral use. It belongs to the anticonvulsant therapeutic class and works by enhancing inhibitory neurotransmission, making it useful as adjunctive therapy for seizures in epilepsy, including Lennox‑Gastaut syndrome, and for control of refractory partial seizures.

GNH USA supplies Likozam as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Clobazam is used in the management of seizure disorders within the epilepsy disease family.

Lennox‑Gastaut syndrome: reduces seizure frequency as adjunctive therapy. Refractory partial seizures: provides additional seizure control when other agents are insufficient. Other epilepsy types: may be used as adjunctive treatment to improve overall seizure management.

Clobazam may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Drowsiness: feeling unusually sleepy or fatigued. - Dizziness: sensation of light‑headedness or unsteadiness. - Ataxia: impaired coordination and balance. - Cognitive impairment: difficulty concentrating or memory lapses. - Fatigue: persistent lack of energy. - Headache: mild to moderate head pain.

Serious or Rare Side Effects: - Severe depression or suicidal thoughts: mood changes requiring immediate medical attention. - Respiratory depression: slowed breathing, especially with other CNS depressants. - Severe skin reactions: rash, Stevens‑Johnson syndrome, or toxic epidermal necrolysis. - Blood dyscrasias: unusual bleeding or low blood cell counts. - Hepatic dysfunction: signs of liver injury such as jaundice. - Anaphylaxis: rare allergic reaction with swelling, hives, or difficulty breathing.

When prescribing or dispensing clobazam, several safety considerations are recommended.

Assess renal and hepatic function: adjust therapy if impairment is present. Monitor for sedation: advise patients to avoid operating machinery until they know how the drug affects them. Avoid abrupt discontinuation: taper the dose under medical supervision to prevent withdrawal seizures. Use caution in patients with a history of depression or suicidal ideation: monitor mood closely. Store at ambient temperature (below 25°C): keep in the original pack, protect from moisture.

Clobazam can interact with other medicines, affecting its safety and effectiveness.

Major Interactions (Avoid): - Other CNS depressants (e.g., barbiturates, opioids): risk of profound sedation and respiratory depression. - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may increase clobazam plasma concentrations. - Carbamazepine (enzyme inducer): may reduce clobazam efficacy.

Moderate Interactions (Monitor Closely): - Alcohol: additive central nervous system depression. - CNS‑active antihistamines: may enhance sedation. - Antidepressants (e.g., SSRIs): monitor for mood changes or increased side effects.